This study combines a systematic review and meta-analysis with a single case report to characterize P450 oxidoreductase deficiency (PORD). The review included 167 patients from 50 studies, while the case report detailed a 7-month-old infant with a novel POR mutation. The primary focus was on clinical findings, allele frequencies, and surgical outcomes, rather than a specific therapeutic intervention for the broader cohort.
Clinical analysis of the 167 patients revealed significant phenotypic prevalence. Skeletal deformities were observed in 124 cases (74.25%), and gonadal deformities in 121 cases (72.46%). Hormonal abnormalities or delayed puberty affected 127 patients (76.05%), and adrenal insufficiency or crisis was noted in 108 patients (64.67%). Among female patients, ovarian cysts were observed in 36 individuals (40.00%).
Genetic analysis identified specific allele frequencies for known variants. The p.R457H variant was found in 27.25% of all PORD patients, whereas the p.A287P variant was present in 14.97%. In the Chinese patient subset, the p.R457H variant frequency was higher at 38.64%. The case report described a novel p.G146fs*111 mutation associated with frontal bossing, craniosynostosis, flat nasal bridge, proximal radioulnar synostosis, clitoromegaly, partial labial fusion, and steroid hormone abnormalities.
In the case report, surgical intervention involving bilateral mandibular distraction osteogenesis and cranial reconstruction alleviated airway obstruction, swallowing difficulty, and craniosynostosis. Safety and tolerability data were not reported for the systematic review cohort, and adverse events were not documented. Key limitations include the observational nature of the data, lack of p-values or confidence intervals, and absence of long-term follow-up. Practice relevance emphasizes that management requires multidisciplinary collaboration, including individualized steroid replacement.
View Original Abstract ↓
BackgroundCytochrome P450 oxidoreductase deficiency (PORD) is an ultra-rare autosomal recessive disorder caused by mutations in the POR gene and characterized by highly heterogeneous skeletal, genital, and endocrine manifestations. Owing to this complexity, PORD remains frequently underrecognized in clinical practice, and integrated clinical–genetic syntheses remain limited.MethodsA retrospective analysis was conducted on the clinical data of a PORD patient treated at Shenzhen Children’s Hospital. Relevant literature was retrieved from PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI). Reported cases were analyzed with respect to sex, age, geographic distribution, clinical manifestations, and POR gene variants.ResultsThe patient from our hospital, a 7-month-old infant, presented with characteristic features including frontal bossing, craniosynostosis, flat nasal bridge, proximal radioulnar synostosis, clitoromegaly, partial labial fusion, and steroid hormone abnormalities. Genetic testing identified compound heterozygous variants, p.G146fs*111, a novel mutation, and p.R457H. The patient underwent bilateral mandibular distraction osteogenesis and cranial reconstruction, which alleviated airway obstruction, swallowing difficulty, and craniosynostosis. A total of 50 eligible studies were identified, comprising 167 patients (male:female = 77:90). The major clinical findings were skeletal deformities in 124 cases (74.25%), gonadal deformities in 121 (72.46%), hormonal abnormalities or delayed puberty in 127 (76.05%), and adrenal insufficiency or crisis in 108 (64.67%). Additionally, ovarian cysts were observed in 36 female patients (40.00%). Among all patients, the allele frequency of the p.R457H variant was 27.25%, while that of the p.A287P variant was 14.97%. In the 22 Chinese patients, the allele frequency of the p.R457H variant reached 38.64%.ConclusionWe report the clinical features of a PORD patient carrying a novel POR mutation, p.G146fs*111. PORD typically presents with skeletal and genital malformations as well as adrenal insufficiency. Management requires multidisciplinary collaboration, including individualized steroid replacement, regular blood pressure monitoring, and surgical intervention when necessary. The p.R457H variant may represent a hotspot mutation in East Asian populations.